The FDA-approved drug combination specifically targets low-grade serous ovarian cancer, which primarily affects younger women ...

A cancer diagnosis can be overwhelming. From learning about treatment to sharing news with family and friends and knowing your life may look different than anticipated, a cancer journey is filled with ...

As immunotherapy becomes a cornerstone of cancer treatment, some of the top U.S. cancer centers and health systems are accelerating research efforts to identify the biological mechanisms behind ...

Academic cancer centers show significantly better survival outcomes for CLL and MCL patients compared with community settings. Younger patients, high-risk disease features, and higher clinical trial ...